Ketamine is a dissociative anesthetic, meaning:

A. Etomidate has a rapid onset of action and rapid recovery, which makes it highly useful for induction of anesthesia. After intravenous administration, its effects occur within 30–60 seconds, and patients often regain consciousness quickly after a single dose. This rapid onset and short duration help control anesthesia more precisely, especially for short proceduresor when a patient needs to regain consciousness quickly.

B. Etomidate provides sedation and hypnosis but has no analgesic properties. This means that although the patient may be unconscious, painful stimuli may still provoke physiological responses, so additional analgesics (like opioids) are often requiredduring painful procedures.

C. Etomidate is short-acting, with a duration of action of 3–5 minutesafter a single IV induction dose. Its brief effect allows for rapid adjustment of sedation depth, making it ideal for situations requiring precise control over anesthesia depth or in critically ill patients.

D. Etomidate is not an inhalation anesthetic. It is an intravenous sedative-hypnoticused primarily for induction of general anesthesiaand procedural sedation. Inhalation anesthetics, such as sevoflurane, desflurane, or halothane, are administered via the lungs, whereas etomidate is given intravenously. This makes option D the correct choice for “all of the following are correct except.”

E. Etomidate is classified as a sedative-hypnotic. It induces unconsciousness and sedationwithout significant cardiovascular or respiratory depression at induction doses, which makes it a preferred agent in patients who are hemodynamically unstable.

A. Halothane was historically the most widely used inhalation anestheticfor general anesthesia, especially during the mid-20th century. It was favored for its potency, ease of administration, and smooth induction.

B. Halothane was withdrawn from widespread clinical usein many countries because of its potential for hepatotoxicity, which could lead to halothane-induced hepatitis, a rare but sometimes fatal liver injury. This risk, combined with safer alternatives, led to its decline in popularity.

C. Halothane is not an intravenous (IV) anesthetic. It is administered via inhalation using a vaporizer, which allows the anesthesiologist to control the concentration delivered to the patient’s lungs. IV anesthetics include agents such as propofol, etomidate, and ketamine, which act through different mechanisms and are delivered systemically rather than through inhalation. Therefore, calling halothane an IV anesthetic is incorrect and is the correct answer for this “except” question.

D. Halothane is essentially obsolete in the United Statesand has been replaced by newer inhalation anesthetics such as sevoflurane, desflurane, and isoflurane, which have lower toxicity profiles and faster recovery times. It is still occasionally used in some countries where cost or availability limits access to newer agents.